These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 11888337)

  • 1. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
    Suzuki T; Matsuzaka H
    CNS Drugs; 2002; 16(3):165-74. PubMed ID: 11888337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing antipsychotic-induced acute and tardive dystonia.
    Raja M
    Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Dependent Effects of Lithium Treatment on the Aggravation of Antipsychotic-Induced Pisa Syndrome.
    Hsieh HT; Yeh YW
    Clin Neuropharmacol; 2020; 43(3):90-91. PubMed ID: 32384312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic-dopaminergic imbalance in Pisa syndrome.
    Villarejo A; Camacho A; García-Ramos R; Moreno T; Penas M; Juntas R; Ruiz J
    Clin Neuropharmacol; 2003; 26(3):119-21. PubMed ID: 12782913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotic-Induced Pisa Syndrome: A 2-Year Follow-up Study.
    Lee YF
    Clin Neuropharmacol; 2018; 41(2):60-63. PubMed ID: 29533362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.
    Loonen AJ; Ivanova SA
    J Psychopharmacol; 2021 Jan; 35(1):3-14. PubMed ID: 32900259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of the Pisa syndrome.
    Suzuki T; Koizumi J; Moroji T; Sakuma K; Hori M; Hori T
    Acta Psychiatr Scand; 1990 Dec; 82(6):454-7. PubMed ID: 1981297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pisa syndrome].
    Harada K; Saito T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):199-202. PubMed ID: 12876965
    [No Abstract]   [Full Text] [Related]  

  • 11. Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.
    Miodownik C; Lerner V; Witztum E
    Isr J Psychiatry Relat Sci; 2011; 48(3):195-200. PubMed ID: 22141144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
    Iuppa CA; Diefenderfer LA
    Ann Pharmacother; 2013 Sep; 47(9):1223-8. PubMed ID: 24259741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tardive dyskinesia.
    Egan MF; Apud J; Wyatt RJ
    Schizophr Bull; 1997; 23(4):583-609. PubMed ID: 9365997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome).
    Suzuki T; Hori T; Baba A; Abe S; Shiraishi H; Moroji T; Piletz JE
    J Clin Psychopharmacol; 1999 Jun; 19(3):277-80. PubMed ID: 10350039
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary anticholinergic-responsive Pisa syndrome.
    Bhattacharya KF; Giannakikou I; Munroe N; Chaudhuri KR
    Mov Disord; 2000 Nov; 15(6):1285-7. PubMed ID: 11104229
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of tardive dyskinesia: use of dopamine-depleting agents.
    Fahn S
    Clin Neuropharmacol; 1983 Jun; 6(2):151-8. PubMed ID: 6133619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?
    Desmarais JE; Beauclair L; Margolese HC
    J Psychopharmacol; 2012 Sep; 26(9):1167-74. PubMed ID: 22651987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of 32 cases of tardive dystonia.
    Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ
    Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.